A story coming out of Australian Federal Court is highlighting questionable practices, not only by drug companies, but also by STM publishing giant Elsevier, in the promotion of the now-withdrawn anti-arthritis drug Vioxx. It’s reported that drug companies ghostwrite articles favorable to their products, then shop around for a “lead author.” Excerpta Medica, a division of Elsevier, also [...]
Filed under: Copyright & Legal Issues, Scholarly publication | Tagged: Elsevier, Medical ghostwriters, Merck, Vioxx | Leave a Comment »
